Report Publication Announcement • Dec 15, 2015
Report Publication Announcement
Open in ViewerOpens in native device viewer
Press Release Lure (France), December 15, 2015
December 15, 2015 (Lure, France) – Vétoquinol published its calendar of financial communication for 2016.
| January 21, 2016 | 2015 Annual revenues (after market) |
|---|---|
| March 21, 2016 | 2015 Annual results (after market) |
| April 19, 2016 | 2016 First quarter revenues (after market) |
| May 24, 2016 | Annual shareholders' meeting |
| June 6, 2016 | Dividend distribution |
| July 28, 2016 | 2016 Interim revenues and interim results (after market) |
| October 18, 2016 | 2016 Third quarter revenues (after market) |
| January 26, 2017 | 2016 Annual revenues (after market) |
Next update: 2015 Annual revenues – January 21, 2016 after market close
Vétoquinol is a leading global player in the animal health sector serving both the livestock (cattle and pigs) and pet (dogs and cats) markets.
An independent pure player, Vétoquinol designs, develops and sells veterinary drugs and non-medicinal products in Europe, the Americas and the Asia Pacific region.
Since its foundation in 1933, Vétoquinol has pursued a strategy combining innovation with geographical diversification. The Group's hybrid growth is driven by the reinforcement of its product portfolio coupled with acquisitions in high potential growth markets. Vétoquinol employs 2,024 people at June 30th, 2015. Vétoquinol has been listed on NYSE Euronext Paris since 2006 (symbol: VETO).
For any information, contact: VETOQUINOL KEIMA COMMUNICATION Investor Relations Marie-Josée Aubry-Rota Tel: +33 (0)3 84 62 59 88 [email protected]
Investor & Media Relations Emmanuel Dovergne Tel: +33 (0)1 56 43 44 63 [email protected]
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.